191 related articles for article (PubMed ID: 20180585)
1. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo.
Barth BM; Sharma R; Altinoğlu EI; Morgan TT; Shanmugavelandy SS; Kaiser JM; McGovern C; Matters GL; Smith JP; Kester M; Adair JH
ACS Nano; 2010 Mar; 4(3):1279-87. PubMed ID: 20180585
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer.
Altinoğlu EI; Russin TJ; Kaiser JM; Barth BM; Eklund PC; Kester M; Adair JH
ACS Nano; 2008 Oct; 2(10):2075-84. PubMed ID: 19206454
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-Targeted Calcium Phosphosilicate Nanoparticles for Effective Imaging of Pancreatic and Prostate Cancer.
Abraham T; McGovern CO; Linton SS; Wilczynski Z; Adair JH; Matters GL
Int J Nanomedicine; 2021; 16():2297-2309. PubMed ID: 33776434
[TBL] [Abstract][Full Text] [Related]
4. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia.
Barth BM; I Altinoğlu E; Shanmugavelandy SS; Kaiser JM; Crespo-Gonzalez D; DiVittore NA; McGovern C; Goff TM; Keasey NR; Adair JH; Loughran TP; Claxton DF; Kester M
ACS Nano; 2011 Jul; 5(7):5325-37. PubMed ID: 21675727
[TBL] [Abstract][Full Text] [Related]
5. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
Mukerjee A; Ranjan AP; Vishwanatha JK
J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
[TBL] [Abstract][Full Text] [Related]
6. Avidin-conjugated calcium phosphate nanoparticles as a modular targeting system for the attachment of biotinylated molecules in vitro and in vivo.
van der Meer SB; Knuschke T; Frede A; Schulze N; Westendorf AM; Epple M
Acta Biomater; 2017 Jul; 57():414-425. PubMed ID: 28552820
[TBL] [Abstract][Full Text] [Related]
7. Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts.
Bussard KM; Gigliotti CM; Adair BM; Snyder JM; Gigliotti NT; Loc WS; Wilczynski ZR; Liu ZK; Meisel K; Zemanek C; Mastro AM; Shupp AB; McGovern C; Matters GL; Adair JH
Nanomedicine; 2021 Jun; 34():102383. PubMed ID: 33722692
[TBL] [Abstract][Full Text] [Related]
8. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity.
Pulkkinen M; Pikkarainen J; Wirth T; Tarvainen T; Haapa-aho V; Korhonen H; Seppälä J; Järvinen K
Eur J Pharm Biopharm; 2008 Sep; 70(1):66-74. PubMed ID: 18555675
[TBL] [Abstract][Full Text] [Related]
9. PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.
Barth BM; Shanmugavelandy SS; Kaiser JM; McGovern C; Altınoğlu Eİ; Haakenson JK; Hengst JA; Gilius EL; Knupp SA; Fox TE; Smith JP; Ritty TM; Adair JH; Kester M
ACS Nano; 2013 Mar; 7(3):2132-44. PubMed ID: 23373542
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
11. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C
Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles.
Yang L; Mao H; Cao Z; Wang YA; Peng X; Wang X; Sajja HK; Wang L; Duan H; Ni C; Staley CA; Wood WC; Gao X; Nie S
Gastroenterology; 2009 May; 136(5):1514-25.e2. PubMed ID: 19208341
[TBL] [Abstract][Full Text] [Related]
14. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma.
Clawson GA; Abraham T; Pan W; Tang X; Linton SS; McGovern CO; Loc WS; Smith JP; Butler PJ; Kester M; Adair JH; Matters GL
Nucleic Acid Ther; 2017 Feb; 27(1):23-35. PubMed ID: 27754762
[TBL] [Abstract][Full Text] [Related]
15. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles.
Qian C; Wang Y; Chen Y; Zeng L; Zhang Q; Shuai X; Huang K
Biomaterials; 2013 Aug; 34(26):6175-84. PubMed ID: 23721794
[TBL] [Abstract][Full Text] [Related]
16. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical examination of cholecystokinin and gastrin receptors (CCK-2/gastrin-R) expression in normal and exocrine cancerous human pancreatic tissues.
Sellam F; Harir N; Khaled MB; Mrabent NM; Belkralladi H; Tou A; Diaf M; Salah R; Moulessehoul S
Pancreatology; 2015; 15(6):661-6. PubMed ID: 26520651
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
Grünwald B; Vandooren J; Locatelli E; Fiten P; Opdenakker G; Proost P; Krüger A; Lellouche JP; Israel LL; Shenkman L; Comes Franchini M
J Control Release; 2016 Oct; 239():39-48. PubMed ID: 27545397
[TBL] [Abstract][Full Text] [Related]
19. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
20. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
